Vasodilator effects of the endothelin ET(A) receptor selective antagonist BMS-193884 in healthy men

AIMS: A number of endothelin receptor antagonists (ERAs) are currently in clinical development as potential therapies in states characterized by vasoconstriction, such as systemic hypertension. We investigated the haemodynamic effects of locally and systemically active doses of BMS-193884, an endoth...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Dhaun, Neeraj, Strachan, Fiona E, Newby, David E, Johnston, Neil R, Ford, Neville F, Hammett, Janis L, Palmisano, Maria, Webb, David J
Médium: Artigo
Jazyk:Inglês
Vydáno: Blackwell Science Inc 2005
Témata:
Pharmacokinetics and Pharmacodynamics
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC1884878/
https://ncbi.nlm.nih.gov/pubmed/16305585
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1365-2125.2005.02503.x
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky